In summary, genetic predisposition to higher circulating levels of IL-6, assessed by leveraging GWAS results and aggregating common variant effects across the entire genome through a PRS approach, was positively associated with AD incidence in two independent population-based cohorts. This evidence concerns the gene IL6 and Alzheimer disease.